New program at Rice University to educate corporate leaders on innovation

tables have turned

A new program within Rice University's Executive Education school will foster education for corporate innovation. Photo courtesy of Rice

As important as it is to foster innovation among startups, there's another side of the equation that needs to be addressed, and a new program at Rice University plans to do exactly that.

Executive Education at Rice University's Jones Graduate School of Business, which creates peer-based learning and professional programs for business leaders, has created a new program called Corporate Innovation. The program came about as Executive Education, which has existed since the '70s, has evolved over the past few years to create courses and programs that equip business leaders with key management tools in a holistic way.

"We realized we need to open the innovation box," says Zoran Perunovic, director of Executive Education and is also a member of the Innovation Corridor committee and a mentor at TMCx.

The program, which is open for registration and will take place September 28-30, will flip the script on how innovation is normally discussed and observed and instead take a holistic approach to innovation in a corporate setting.

"In the innovation space, you have two lines — one is the entrepreneurial and the other is happening in large, established organizations," Perunovic tells InnovationMap. "The mechanisms of innovation within in those companies are different than the entrepreneurial."

The course's professor is Jing Zhou, Mary Gibbs Jones Professor of Management and Psychology – Organizational Behavior, and she says that when people think "innovation" they think of startups or technology. However, when it comes to innovation at the corporate level, it's so much more than that.

"In the past, we think about corporate innovation, we think about technological advancements. Because we have so many world-class organizations in Houston, we feel like we are doing a good job," Zhou says.

"Innovation definitely includes technology, but it also involves new business models, new way of meeting customers, new work processes — everything we do in a large corporation, there's always a better way of doing it. That's our definition of our corporate innovation."

Zoran Perunovic (left) anf Jing Zhou created the Corporate Innovation program housed in Rice's Executive Education department. Photos courtesy of Rice

Zhou and Perunovic designed the program to target business professionals from all areas of the corporate world.

"People, managers, professionals, executives in all functional areas of business can benefit from this program," Zhou says. "We don't teach to just one function area. We teach the fundamental principles of how to drive innovation and broaden the cognitive space."

Perunovic concurs with his colleague and adds that, "everyone is relevant — that's the future of innovation." Another aspect of the program that's forward thinking is the idea of cross-industry innovation collaboration.

"In all our programs, especially this one, we are not encouraging members from one type of industry to join. We want diversity of industry," Perunovic says.

The program has an advisory board comprised of business leaders in Houston. The program's board is made up of:

  • Tanya Acevedo, chief technology officer of Houston Airport System
  • Barbara Burger, vice president of innovation at Chevron and president of Chevron Technology Ventures
  • Gareth Burton, vice president of technology at American Bureau of Shipping
  • David Hatrick, vice president of innovation at Huntsman Advanced Materials
  • Roberta L. Schwartz, executive vice president and chief innovation officer at Houston Methodist

Industry, position, and company notwithstanding, the program has value across the board in Houston, now more than ever.

"Innovation is no longer optional for large organizations," Zhou says. "It's required in whatever you do, and whatever space you're competing in."

Can corporations be compassionate? Rice University researchers are figuring that out. Pexels

Rice University research looks into corporate responsibility for compassion

Houston voices

Since the early 2000s, the business of doing business has changed its looks markedly. As corporations gain power and reach, many in the public are subjecting them to increasingly insistent questions about their impact on the lives of workers, the environment and society at large.

At the same time, academics have focused more attention on compassion in management and business organizations. Today, considerable research parses the way corporate conduct affects employees, laid-off workers and the well-being of society as a whole. A considerable segment of this academic literature advocates for what once seemed like an oxymoron: compassion in corporate management.

Most of the recent research on compassion focuses on individuals and the group. Most management research, meanwhile, centers on economic performance and efficiency. In an editorial for Journal of Management, though, Rice Business Mary Gibbs Jones Professor Emeritus of Management Jennifer George argues that compassion research can actually be a jumping-off point for focus on social problems, well-being and identifying the conditions under which organizations do the least harm.

But what is compassion in business, exactly? According to George, it's the practice of setting up organizations so that they respond to the vulnerable groups in their orbit. To do this, George says, companies should reconsider the concept of "American Corporate Capitalism (ACC)," which operates when corporations, workers and consumers pursue self-interest. ACC follows the laws of supply and demand, and is founded on the bedrock principles of respect for private property, an emphasis on economic growth and using profits as the measuring stick for making business decision.

Make no mistake, George adds: "ACC is an ideology." A host of institutions provide the underpinnings that allow ACC to flourish, among them the legal system, governmental agencies, stock markets, media and advertising and trade organizations.

But, notes George, the rewards from American Corporate Capitalism are narrowing sharply. ACC, she contends, now concentrates benefits upon fewer and fewer people. One article she cites suggests that outsized CEO salaries and compensation, coupled with large income inequality within a company, may result in organizations that do harm to their workers.

In fact, "the tenets of ACC seem to downplay the importance of compassionate organizing," says George. Harm done by corporations, such as laying off employees, may occur unintentionally, but those decisions still cause suffering. ACC, she says, "has the potential to create conditions under which compassion is much less likely to occur."

As a result, it's crucial to closely examine the tensions and contradictions between ACC and compassion. A focus on compassion would "identify the conditions under which organizations inflict the least harm and alleviate the most suffering," George writes.

She proposes a wide-ranging agenda to achieve this. First, researchers should look at organizational decision-making to track the influence of ACC values and whether criteria such as dominance or hierarchy override harmony and egalitarianism. Identifying the factors that spur organizations to favor only shareholders and customers over employees and neighboring communities could offer insights for management. Other research, George suggests, ought to examine a range of companies operating in the same sector, tracing which cause more damage and which are more successful at reducing suffering.

Finally, George says, academics should develop case studies of organizations that successfully pursue policies such as employing the disabled – policies designed to promote the well-being of vulnerable groups inside and outside the company.

Because corporations wield such vast influence, the harm they do can reach wide swaths of the population. It's time, George writes, for researchers to examine the disconnects between prevailing corporate culture and compassion. Effectively done, she says, such research could vault over the ivory battlements into the heart of everyday life.

------

This story originally ran on Rice Business Wisdom in 2019.

Based on research from Jennifer M. George, the Mary Gibbs Jones Professor Emeritus of Management in Organizational Behavior at the Jones Graduate School of Business at Rice University.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

7+ can't-miss Houston business and innovation events in June 2026

where to be

Editor's note: The FIFA World Cup comes to Houston this month, joined by major energy conferences and a lineup of fan-favorite, recurring events. Here’s what not to miss and how to register. Please note: this article may be updated to add more events.


June 1-4 — CLEANPOWER 2026 Conference and Exhibition

CLEANPOWER unites policymakers, experts, and corporate leaders to solve the challenges that none can solve alone. This must-attend, four-day conference is packed with cutting-edge discussions about wind, solar, storage, and transmission; dealmaking; networking; and fun.

This event begins June 1 at the George R. Brown Convention Center. Register here.

June 2 — Humans of Healthcare

Houston Methodist Center for Innovation will present its quarterly speaker series, Humans of Healthcare. The series will feature a panel of experts who will share about their career paths and discuss the nuances of the health care industry. This month's session will focus on today’s nursing landscape, the industry’s expectations of nurses and what career paths are possible in the field.

The event is Tuesday, June 2, from 5-6:30 p.m. at the Ion. Register here.

June 9 — Greentown Go Make Kickoff

Head to the Ion to celebrate the Greentown Go Make 2026 cohort. The open-innovation program with Shell Catalysts & Technologies and Technip Energies focuses on catalytic solutions for industrial decarbonization and the energy transition. Hear pitches from the founders and network with a select group of startups while enjoying food and drink.

This event is Tuesday, June 9, from 5:30-8 p.m. Register here.

June 9-10 — Texas Brain Economy Summit

The Center for Houston’s Future and UTMB are bringing the Texas Brain Economy Summit back to Houston this summer to continue to position the region as a global leader in brain health. Expect to hear from leaders of global institutions, including the World Economic Forum, U.S. Chamber of Commerce, McKinsey Health Institute, Global Brain Economy Initiative, Davos Alzheimer’s Collaborative, Business Collaborative for Brain Health (UsAgainstAlzheimer’s), Rice University, Memorial Hermann, MD Anderson and many others. Read InnovationMap's full preview of the event here.

This event begins Tuesday, June 9. Purchase tickets here.

June 10 — MIT Future of Healthcare Technology Forum

The MIT Club of South Texas will host an in-person forum to explore how innovation, government and policy are changing the healthcare industry. The event will feature MIT alumni and Houston healthcare leaders, including Dr. Tim Boone, dean of the Texas A&M School of Engineering Medicine; Cynthia Reinhart-King, chair of bioengineering at Rice University; Dr. Tony Lin, CEO and chairman emeritus of Kelsey-Seybold Clinic; and others.

This event is Wednesday, June 10, from 5:15-8:30 p.m. at the TAMU EnMed Building. Register here.

June 11 — Goals & Gigawatts: Houston Energy & Climate Week The Power of & Kickoff Party

Come watch the Mexico City FIFA opening match while celebrating energy and innovation at the Goals & Gigawatts Kickoff Party. The event will feature food, drinks, and a showcase on Houston Energy & Climate Week. Learn what to expect and how to get involved in HECW before closing the night with a DJ and karaoke.

This event is Thursday, June 11, from 1:30-6:30 p.m. Find more information here.

June 16-17 — Energy Projects Conference & Expo

The Energy Projects Conference & Expo (EPC Show) is the largest event in North America for professionals working at the heart of major energy projects. The essential event for engineering, construction, commissioning, operations and maintenance across multiple energy sectors brings together five leading conferences under one roof. Conference subjects span LNG exporting, hydrogen and ammonia, midstream, petrochem and refining, and sustainable aviation fuels.

This event begins June 16 at George R. Brown Convention Center. Register here.

June 25 – NASA Tech Talk

Every fourth Thursday of the month, NASA experts, including longtime engineer Montgomery Goforth, present on technology development challenges NASA’s Johnson Space Center and the larger aerospace community are facing, and how they can be leveraged by Houston’s innovation community. Stick around after for drinks and networking at Second Draught.

This event is Thursday, June 25, from 6-7 p.m. at the Ion. Register here.

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”

5 must-read innovation headlines: Pharma giant considers Houston hub + more

Trending news

Editor's note: With May coming to a close, it's time to look back at the biggest innovation headlines for the second half of the month. Major moves were made in May, with NuScale Power entering the market, Persona AI inking a deal with Under Armour, and a pharma giant considering Houston for its next manufacturing hub. Here are the most-read InnovationMap stories published May 15-29, 2026:

1. Pharma giant considers Houston for $1 billion manufacturing campus

Another pharmaceutical giant is considering Houston’s Generation Park for a manufacturing hub. According to a recent filing with the Texas Jobs, Energy, Technology and Innovation (JETI) program, Bristol Myers Squibb Co. is considering the northeast Houston management district for a new $1 billion multi-modal pharmaceutical manufacturing campus.

2. Modular nuclear reactor co. NuScale Power moves into Houston market

The nuclear energy renaissance continues in Texas with an announcement by NuScale Power. The Oregon-based provider of proprietary and innovative advanced small modular reactor (SMR) nuclear technology announced in April it would be opening office space in Houston’s CityCentre.

3. Persona AI teams with Under Armour to protect next-gen robots

Houston-based Persona AI has cemented a partnership with sportswear manufacturer Under Armour to provide materials to protect future robots operating in dangerous conditions. Through the partnership, Persona AI and Under Armour will launch a research initiative to explore whether advanced performance textiles can improve the durability and resilience of humanoid robots operating in harsh industrial environments.

4. Houston quantum energy chip startup emerges from stealth with $12M round

Houston-based Casimir has emerged from stealth with a $12 million seed round to commercialize its quantum energy chip. The round was led by Austin-based Scout Ventures. Lavrock Ventures, Cottonwood Technology, Capital Factory, American Deep Tech, and Tim Draper of Draper Associates also participated in the round. The oversubscribed round exceeded the company’s original $8 million target.

5. Global summit spotlights Houston's growing role in brain health, innovation

The Center for Houston’s Future and UTMB are bringing the Texas Brain Economy Summit back to Houston this summer to continue to position the region as a global leader in brain health. The summit, held June 9-10 at the Texas Medical Center's Helix Park, will bring together more than 500 executives, researchers, policymakers and innovators from around the world to discuss the global brain economy.

View All Listings